Publications in collaboration with researchers from Instituto de Investigación Sanitaria del Principado de Asturias (14)

2023

  1. Exercise and immunity: Beliefs and facts

    The Active Female: Health Issues throughout the Lifespan (Springer International Publishing), pp. 503-526

  2. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  3. Immunometabolic Profile Associated with Progressive Damage of the Intestinal Mucosa in Adults Screened for Colorectal Cancer: Association with Diet

    International Journal of Molecular Sciences, Vol. 24, Núm. 22

2020

  1. Erratum: Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus (Rheumatology (2020) 59 (1752-1764) DOI: 10.1093/rheumatology/keaa016)

    Rheumatology (United Kingdom)

  2. Glyca levels during the earliest stages of rheumatoid arthritis: Potential use as a biomarker of subclinical cardiovascular disease

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19

2019

  1. Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 2, pp. 135-143

  2. IRF4 and IRGS delineate clinically relevant gene expression signatures in systemic lupus erythematosus and rheumatoid arthritis

    Frontiers in Immunology, Vol. 10, Núm. JAN

  3. Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Anti-high-density lipoprotein antibodies and antioxidant dysfunction in immune-driven diseases

    Frontiers in Medicine, Vol. 5, Núm. APR

  2. Anti-high-density lipoprotein antibodies and antioxidant dysfunction in immune-driven diseases

    Frontiers in Medicine, Vol. 5, Núm. APR

  3. Could Fecal Phenylacetic and Phenylpropionic Acids Be Used as Indicators of Health Status?

    Journal of Agricultural and Food Chemistry, Vol. 66, Núm. 40, pp. 10438-10446

  4. Heterogeneity of the type I interferon signature in rheumatoid arthritis: A potential limitation for its use as a clinical biomarker

    Frontiers in Immunology, Vol. 8, Núm. JAN

  5. Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes

    Frontiers in immunology, Vol. 9, pp. 2351

  6. The role of gut microbiota in lupus: what we know in 2018?

    Expert Review of Clinical Immunology, Vol. 14, Núm. 10, pp. 787-792